1365 related articles for article (PubMed ID: 8760289)
1. Transcriptional regulation of the human CD9 gene: characterization of the 5'-flanking region.
Le Naour F; Prenant M; Francastel C; Rubinstein E; Uzan G; Boucheix C
Oncogene; 1996 Aug; 13(3):481-6. PubMed ID: 8760289
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Organization of the human CD9 gene.
Rubinstein E; Benoit P; Billard M; Plaisance S; Prenant M; Uzan G; Boucheix C
Genomics; 1993 Apr; 16(1):132-8. PubMed ID: 8486348
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene.
Nomura M; Tsujimura A; Begum NA; Matsumoto M; Wabiko H; Toyoshima K; Seya T
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):353-65. PubMed ID: 11023821
[TBL] [Abstract][Full Text] [Related]
6. CD9 antigen is an accessory subunit of the VLA integrin complexes.
Rubinstein E; Le Naour F; Billard M; Prenant M; Boucheix C
Eur J Immunol; 1994 Dec; 24(12):3005-13. PubMed ID: 7528664
[TBL] [Abstract][Full Text] [Related]
7. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
8. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
Rubinstein E; Le Naour F; Lagaudrière-Gesbert C; Billard M; Conjeaud H; Boucheix C
Eur J Immunol; 1996 Nov; 26(11):2657-65. PubMed ID: 8921952
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
10. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
11. Identification of regulatory elements of human alpha 6 integrin subunit gene.
Nishida K; Kitazawa R; Mizuno K; Maeda S; Kitazawa S
Biochem Biophys Res Commun; 1997 Dec; 241(2):258-63. PubMed ID: 9425259
[TBL] [Abstract][Full Text] [Related]
12. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
[TBL] [Abstract][Full Text] [Related]
13. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
14. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
Thompson JR; Huang DY; Gudas LJ
Cell Growth Differ; 1998 Dec; 9(12):969-81. PubMed ID: 9869297
[TBL] [Abstract][Full Text] [Related]
15. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region.
Romanelli MG; Lorenzi P; Morandi C
Gene; 2005 Aug; 356():11-8. PubMed ID: 16002244
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of mouse MARCKS promoter in immortalized hippocampal cells.
Wang L; Liu X; Lenox RH
Biochem Biophys Res Commun; 2002 Apr; 292(4):969-79. PubMed ID: 11944910
[TBL] [Abstract][Full Text] [Related]
17. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CD9 expression during TPA treatment of K562 cells.
Le Naour F; Francastel C; Prenant M; Lantz O; Boucheix C; Rubinstein E
Leukemia; 1997 Aug; 11(8):1290-7. PubMed ID: 9264383
[TBL] [Abstract][Full Text] [Related]
20. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma.
Radford KJ; Thorne RF; Hersey P
Biochem Biophys Res Commun; 1996 May; 222(1):13-8. PubMed ID: 8630057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
